Skip to content

The Journal of Headache and Pain

Official Journal of the "European Headache Federation" and of "Lifting The Burden - The Global Campaign against Headache"

The Journal of Headache and Pain Cover Image
Open Access

Anticonvulsant drugs in migraine prophylaxis

The Journal of Headache and PainOfficial Journal of the Italian Society for the Study of Headaches and the Italian Society of Pain Clinicians2:24

https://doi.org/10.1007/s101940170024

Abstract

Anticonvulsant drugs have been used in migraine prophylaxis since 1970. In recent years, new antiepileptic compounds have given rise to much interest in pain control. Migraine prophylaxis is still based on old drugs, and physicians facing this condition are always prompted to use any new possible choice. The most studied drug over last decade has been divalproex sodium, and many papers showed its efficacy in the treatment of episodic migraine, chronic migraine, transformed migraine, and related conditions. Valproate is well tolerated and many dosages have been used successfully. For the newer drugs, such as gabapentin, lamotrigine or topiramate, the evidence is less strong but rapidly increasing in the last 3–4 years. We review the principal characteristics of their use, according to dosages, duration of treatments, side effects, and significant efficacy.

Anticonvulsant drugsCarbamazepineDivalproexGabapentinLamotrigineTopiramateMigraine prophylaxis

Notes

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.